2026
Selected ImmuHub® Publications
Applications of immune repertoire sequencing across cancer immunology, infectious disease, vaccines, autoimmunity and antibody research.
Platform evidence
A growing body of peer-reviewed research
ImmuQuad’s official publication page currently reports 63 SCI papers and a cumulative impact factor of 857.0. The selection below highlights recent and representative repertoire studies.
Metrics are a snapshot of the official publication page accessed in July 2026 and may change as new work is published.
67SCI publications listed
903.6Cumulative impact factor reported
View article ↗
2026
Cold Atmospheric Plasma–Engineered Nanovaccine with Spatiotemporal Sequential Immunization Reprograms Antitumor Immunity
2025
Enhancement of Immune Checkpoint Inhibitor Efficacy by DHX58+ SELL+ T Cells in Advanced Gastric Cancer
2024
T-cell Receptor and B-cell Receptor Repertoires Profiling in Pleural Tuberculosis
2022
Predictive Value of Next-generation Sequencing-based Minimal Residual Disease after CAR-T Cell Therapy
2022
